Handelsbanken Fonder Ab Enanta Pharmaceuticals Inc Transaction History

Handelsbanken Fonder Ab

  • $25.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$56.06 - $74.11 $123,332 - $163,042
-2,200 Reduced 33.85%
4,300 $306,000
Q4 2021

Feb 08, 2022
SELL
$60.19 - $97.37 $36,114 - $58,422
-600 Reduced 8.45%
6,500 $486,000
Q3 2021

Nov 10, 2021
BUY
$41.02 - $58.65 $65,632 - $93,840
1,600 Added 29.09%
7,100 $403,000
Q2 2021

Aug 03, 2021
BUY
$43.76 - $53.11 $240,680 - $292,105
5,500 New
5,500 $242,000

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $109M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email